Prevalence of anaemia in non-pregnant women (aged 15-49) in Bahrain
Bahrain: Prevalence of anaemia in non-pregnant women (aged 15-49) was 20.8% in 2019. ▼ Falling
Prevalence of anaemia in non-pregnant women (aged 15-49) in Bahrain, 2000–2019
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for prevalence of anaemia in non-pregnant women (aged 15-49) in Bahrain is 20.8%, measured in 2019.
That represents a change of up 0.5% on the previous year and down 0.5% over ten years.
Over the whole period, prevalence of anaemia in non-pregnant women (aged 15-49) in Bahrain peaked at 22.5% in 2000 and was at its lowest, 20.5%, in 2013.
Bahrain ranks 40th of 194 countries on this measure, in the top quarter.
The long-run direction has been consistently falling across the 20 years of available data.
Prevalence of anaemia in non-pregnant women (aged 15-49) in Bahrain, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 22.5% | — |
| 2001 | 22.3% | -0.9% |
| 2002 | 22.1% | -0.9% |
| 2003 | 22.0% | -0.5% |
| 2004 | 21.9% | -0.5% |
| 2005 | 21.7% | -0.9% |
| 2006 | 21.5% | -0.9% |
| 2007 | 21.3% | -0.9% |
| 2008 | 21.1% | -0.9% |
| 2009 | 20.9% | -0.9% |
| 2010 | 20.7% | -1.0% |
| 2011 | 20.6% | -0.5% |
| 2012 | 20.6% | +0.0% |
| 2013 | 20.5% | -0.5% |
| 2014 | 20.5% | +0.0% |
| 2015 | 20.6% | +0.5% |
| 2016 | 20.6% | +0.0% |
| 2017 | 20.7% | +0.5% |
| 2018 | 20.7% | +0.0% |
| 2019 | 20.8% | +0.5% |
Bahrain compared with similar countries
- Bahrain's 20.8% is above the median for high income countries, which is 9.7%, 2.1× the median. (63 countries reporting)
- Bahrain's 20.8% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 18.3%, 1.1× the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 21.7% | 20.9% | 22.5% | 10 |
| 2010s | 20.6% | 20.5% | 20.8% | 10 |
Countries ranked near Bahrain
- 37 Yemen 21.5% compare
- 38 Bangladesh 21.3% compare
- 39 Madagascar 20.9% compare
- 40 Malaysia 20.8% compare
- 42 Nepal 20.4% compare
- 42 Ghana 20.4% compare
- 42 Tajikistan 20.4% compare
More gender data for Bahrain
- Child population (UN estimates and projections) 307.73 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.2195 % change on previous year (2030)
- Population 1,457 (2030)
- Working-age population (UN estimates and projections) 1,457 (2030)
- Population (UN estimates and projections), annual growth rate 1.23 % change on previous year (2030)
- Age population, age 00, female, interpolated 9,733 (2025)
- Age population, age 00, male, interpolated 10,092 (2025)
- Age population, age 01, female, interpolated 9,943 (2025)
- Age population, age 01, male, interpolated 10,248 (2025)
- Age population, age 02, female, interpolated 9,619 (2025)
Frequently asked questions
- What is prevalence of anaemia in non-pregnant women (aged 15-49) in Bahrain?
- Prevalence of anaemia in non-pregnant women (aged 15-49) in Bahrain was 20.8% in 2019, according to World Health Organization, Global Health Observatory.
- What is the highest prevalence of anaemia in non-pregnant women (aged 15-49) recorded in Bahrain?
- The highest recorded value was 22.5% in 2000.
- What is the lowest prevalence of anaemia in non-pregnant women (aged 15-49) recorded in Bahrain?
- The lowest recorded value was 20.5% in 2013.
- How does Bahrain rank for prevalence of anaemia in non-pregnant women (aged 15-49)?
- Bahrain ranks 40th out of 194 countries with data for 2019.
- Is prevalence of anaemia in non-pregnant women (aged 15-49) rising or falling in Bahrain?
- Over the last ten years it is down 0.5%. The long-run trend across the full record is falling.
- Where does this Bahrain data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Prevalence of anaemia in non-pregnant women (aged 15-49) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).